Permanens Capital L.P. Buys New Position in CME Group Inc (NASDAQ:CME)

Permanens Capital L.P. purchased a new position in CME Group Inc (NASDAQ:CME) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 250 shares of the financial services provider’s stock, valued at approximately $41,000.

A number of other institutional investors have also modified their holdings of the business. Cognios Capital LLC raised its holdings in shares of CME Group by 10.5% during the 1st quarter. Cognios Capital LLC now owns 13,333 shares of the financial services provider’s stock worth $2,194,000 after acquiring an additional 1,267 shares during the period. Duality Advisers LP purchased a new position in shares of CME Group during the first quarter valued at $4,170,000. Trustco Bank Corp N Y acquired a new position in shares of CME Group during the 1st quarter worth about $247,000. Institutional & Family Asset Management LLC lifted its position in shares of CME Group by 4.9% during the 1st quarter. Institutional & Family Asset Management LLC now owns 17,639 shares of the financial services provider’s stock worth $2,903,000 after purchasing an additional 828 shares during the last quarter. Finally, Northern Trust Corp lifted its position in shares of CME Group by 1.0% during the 1st quarter. Northern Trust Corp now owns 4,212,490 shares of the financial services provider’s stock worth $693,291,000 after purchasing an additional 42,753 shares during the last quarter. Institutional investors own 84.67% of the company’s stock.

Shares of NASDAQ CME opened at $194.11 on Friday. The company has a market cap of $69.30 billion, a PE ratio of 28.46, a price-to-earnings-growth ratio of 4.42 and a beta of 0.24. The firm has a 50-day moving average of $192.25. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.04 and a quick ratio of 1.04. CME Group Inc has a fifty-two week low of $158.35 and a fifty-two week high of $204.56.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, May 1st. The financial services provider reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.02. The business had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.19 billion. CME Group had a return on equity of 9.29% and a net margin of 42.47%. CME Group’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the company posted $1.86 earnings per share. On average, sell-side analysts anticipate that CME Group Inc will post 6.64 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 10th were given a dividend of $0.75 per share. The ex-dividend date was Friday, June 7th. This represents a $3.00 annualized dividend and a yield of 1.55%. CME Group’s dividend payout ratio (DPR) is presently 43.99%.

Several equities research analysts have recently weighed in on CME shares. BidaskClub upgraded CME Group from a “sell” rating to a “hold” rating in a research note on Thursday, April 18th. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a research report on Wednesday, April 17th. ValuEngine lowered CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 20th. Finally, UBS Group decreased their price objective on CME Group from $179.00 to $175.00 and set a “neutral” rating on the stock in a research report on Thursday, May 2nd. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and eight have assigned a buy rating to the stock. CME Group currently has an average rating of “Hold” and a consensus price target of $188.87.

In other CME Group news, Director Elizabeth A. Cook sold 300 shares of the business’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $204.27, for a total transaction of $61,281.00. Following the sale, the director now owns 20,821 shares of the company’s stock, valued at $4,253,105.67. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction on Wednesday, April 3rd. The stock was sold at an average price of $168.27, for a total transaction of $420,675.00. Following the sale, the chief financial officer now directly owns 35,354 shares in the company, valued at approximately $5,949,017.58. The disclosure for this sale can be found here. Insiders have sold 48,873 shares of company stock valued at $9,385,174 over the last 90 days. Company insiders own 1.20% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Story: What are the advantages to having securities held in street name?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.